CDK7 and ER mRNA levels were found to positively correlate in TCGA ER-positive (ER+) breast cancer samples, and patients with ER+ breast cancer who express high levels of CDK7 have a noticeably lower overall survival [138]. This evidence concerns the gene ESR1 and breast carcinoma.